The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center and the National Institute on Aging (NIA) Office of Small Business Research are coming to NYC!
NCI SBIR Development Center Team Leader Andy Kurtz, and NIA Chief of Small Business Research Todd Haim will be presenting funding opportunities, guidance on submitting competitive applications, and other resources for startups developing technologies relevant to cancer, Alzheimer’s Disease, AD-related dementias and aging.
Although the trends reflect improvements in cancer treatments and advances in technology have led to better tools for understanding, detecting, and diagnosing cancer, we still have work to do. In 2017, an estimated 1,688,780 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.
In the United States (US), 5.5 million people currently suffer from Alzheimer's disease (AD) and Alzheimer's Disease-related dementias (ADRD). One in 10 people age 65 and older (10%) has Alzheimer’s, and nearly two-thirds are women. This number is forecast to rise to more than 15 million by 2050. The most expensive disease in America, the cost of caring for those who with Alzheimer’s disease will be an estimated $214B. As part of the National Institute on Aging's (NIA) strategic plan to support the development of innovative strategies and therapies to prevent, diagnose, and treat AD/ADRD, NIA has released several Funding Opportunity Announcement (FOA) through its Small Business Innovation Research Program (SBIR) to encourage research on, and the commercialization of novel therapies, diagnostic devices, mobile technology, and analytic tools for caregivers, health care programs and practices to prevent the onset of AD/ADRD and to reduce the burden on individuals, their families, and society at large.
NCI PRESENTS CURRENT FUNDING OPPORTUNITIES AND INITIATIVES
Program directors will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will highlight several initiatives run by NCI to facilitate the success of SBIR companies.
Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI.
Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due October 10, 2018.
To apply: Send an email to firstname.lastname@example.org and include your name, company name, and non-confidential one-page summary of your project.